If you take the changes in the trial focus it is rather clear that certain results in patients triggered this activity.
So here we go, my prediction of the 150 000 cell injections is consistent with the animal studies and combined with a less damaged eye
THE WINNER, THE HOMERUN of the science.
And one word to Gary. He keeps cleaning up the mess and the mess is almost gone.
And keep is an idiot and this will never change.
And one word to ACTC: Shut up, write your scientific evaluations, get approval for the reverse split, get it done, bring the institutional investors on board
AND MAKE US RICH
"And keep is an idiot and this will never change."
Fighter, you always manage to slip something about me in your posts, which means I've totally gotten under your skin, which makes me almost as happy as yesterdays news did.
reverse split not necessary. the treatment works, so just wait until trials complete. then valuation will be enough without R/S to uplist.
Good post pilot. You earned your donut. Hmmm. might get one myself.
.Good summary by you today. Now it's time for an apricot filled hottie
"apricot filled hottie"? Sounds kind of sexy! lol